Readiness of high-risk populations in the HIV network for prevention trials to participate in HIV vaccine efficacy trials in the United States

AIDS

Volumn 12, Issue 7, 1998, Pages 785-793

  Koblin, Beryl A ^a   Heagerty, Patrick ^b   Sheon, Amy ^c,l   Buchbinder, Susan ^d   Celum, Connie ^e   Douglas, John M ^f   Gross, Michael ^g   Marmor, Michael ^h   Mayer, Kenneth ⁱ   Metzger, David ^j   Seage, George ^g,k  

^a NEW YORK BLOOD CENTER   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d S Francisco Dept of Public Health   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f Denver Department of Public Health ^*  (United States)

^g ABT ASSOCIATES   (United States)

^h NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

ⁱ FENWAY INSTITUTE   (United States)

^j UNIVERSITY OF PENNSYLVANIA   (United States)

^k BOSTON UNIVERSITY   (United States)

^l WESTAT   (United States)

more..

Author keywords

HIV; Homosexual men; Injecting drug users; Vaccine trials; Women

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ALTRUISM; ARTICLE; CITY; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; EDUCATION; FEMALE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MOTIVATION; NONHUMAN; PATIENT ATTITUDE; PRIORITY JOURNAL; PUBLIC HEALTH INSURANCE; RANDOMIZED CONTROLLED TRIAL; TRAVEL; UNITED STATES;

AIDS VACCINES; CLINICAL TRIALS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH EDUCATION; HIV INFECTIONS; HUMANS; MALE; RISK FACTORS; UNITED STATES;

EID: 7144253781     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199807000-00015     Document Type: Article

References (17)

1. Koblin BA, Taylor PE, Avrett S, Stevens CE: The feasibility of HIV-1 vaccine efficacy trials among gay/bisexual men in New York City: Project ACHIEVE. AIDS 1996, 10:1555-1561.
2. Buchbinder SP, Douglas JM, McKirnan DJ, Judson FN, Katz MH, MacQueen K: Feasibility of human immunodeficiency virus vaccine trials in homosexual men in the US: risk behaviors, seroincidence and willingness to participate. J Infect Dis 1996, 174:954-961.
3. Marmor M, Titus S, Harrison C, et al.: Weight loss associated with HIV seroconversion among injection-drug users. J Acquir Immune Defic Syndr 1996, 12:514-518.
4. Graham BS, Wright PF: Candidate AIDS vaccines. N Engl J Med 1995, 333:1331-1339.
5. Haynes BF: HIV vaccines: where we are and where we are going. Lancet 1996, 348:933-937.
6. Sheon AR: Overview: HIV vaccine feasibility studies. AIDS Res Hum Retroviruses 1994, 10 (suppl 2):S195-S196.
7. Mayer KH, Koblin B, Marmor M, Donnell D, Chiasson M, Flanigan T: Contraceptive practices among US women at increased risk for HIV acquisition. XI International Conference on AIDS. Vancouver, July 1996 [abstract ThC4510].
8. Metzger DS, Woody G, Marmor M, Gross M: Risk characteristics of injection drug users (IDUs) participating in the Vaccine Preparedness Study (VPS). XI International Conference on AIDS. Vancouver, July 1996 [abstract TuC2536].
9. Stone E, Seage G, Vittinghoff E, et al.: Predictors of condom failure in a cohort of sexually active gay and bisexual men. XI International Conference on AIDS. Vancouver, July 1996 [abstract TuC2413].
10. Sheon AR: Preventing discrimination against volunteers in preventive HIV vaccine efficacy trials: conference summary. AIDS Res Hum Retroviruses 1995, 11:1309-1311.
11. McCullagh P, Nelder JA: Generalized Linear Models. New York: Chapman and Hall; 1989.
12. Koblin BA, Avrett S, Taylor PE, Stevens CE: Willingness to participate in HIV-1 vaccine efficacy trials and the effect of media events among gay/bisexual men in New York City: Project ACHIEVE. J Acquir Immune Defic Syndr 1997, 15:165-171.
13. Douglas JM Jr, Judson FN, Parks JP, Buchbinder S, McKirnan D: Participation of homosexual/bisexual men in preventive HIV vaccine trials: baseline attitudes and concerns and predicted behaviors during trials. AIDS Res Hum Retroviruses 1994, 10 (suppl 2):S257-S260.
14. Bartholow BN, MacQueen K, Douglas J, Buchbinder S, McKirnan D, Judson F: The decision to participate in HIV vaccine efficacy trials: an assessment of changing willingness among homosexual men. XI International Conference on AIDS. Vancouver, July 1996 [abstract WeC212].
15. Cross M, Seage GR, Mayer KH, Goldstein RS, Losina E, Wold C: Interest among gay/bisexual men in Greater Boston in participating in clinical trials of preventive HIV vaccines. J Acquir Immune Defic Syndr 1996, 12:406-412.
16. Meyers K, Metzger DS, Navaline H, Woody GE, McLellan AT: HIV vaccine trials: will intravenous drug users enroll? Am J Public Health 1994, 84:791-766.
17. Vlahov D, Astemborski J, Solomon L, Calai N, Basarab L, Nelson K: Interest in HIV vaccines among injection drug users in Baltimore, Maryland. AIDS Res Hum Retroviruses 1994, 10:S265-S268.